| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2025-06-27 | ORACLE CORP | CATZ SAFRA
(Chief Executive Officer) |
S | Common Stock | D | 1260508 | $210.35 - $214.25 | $267,244,337 |
| 2025-06-26 | Snowflake Inc. | Slootman Frank
(Director) |
S | Class A Common Stock | D | 731354 | $216.30 - $224.15 | $161,374,977 |
| 2025-06-27 | BridgeBio Pharma, Inc. | Shabet Rose Sharon
(AtLeastTenPercentOwner) |
S | Common Stock | D | 3500000 | $44.00 - $44.00 | $154,000,000 |
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |